- Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in eight countries, and affiliates or offices in 75 countries
Novo Nordisk Net worth 2024 (estimated)
| | How much is Novo Nordisk worth? | Under review
|
Novo Nordisk facts
- Novo Nordisk is controlled by majority shareholder, Novo A/S, which holds approximately 25% of its shares and a majority 75% voting shares
- Novo Nordisk manufactures and markets pharmaceutical products and services
- Key products include diabetes care medications and devices
- Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy
- The company makes several drugs under various brand names, including Levemir, NovoLog, Novolin R, NovoSeven, NovoEight and Victoza
- Novo Nordisk employs more than 40,000 people globally, and markets its products in 180 countries
- The corporation was created in 1989 through a merger of two Danish companies which date back to the 1920s
- The Novo Nordisk logo is the Apis bull, one of the sacred animals of ancient Egypt
- Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA)
- The company was ranked 25th among 100 best companies to work for in 2010 by Fortune
Bio / wiki sources: Wikipedia, accounts on social media, content from our users.
|
|
